AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glycofit-G1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Tertius Life Sciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glycofit-G1 Tablet SR

Diabetica Duo SR tablets are a dual-action antidiabetic medication used in adult patients with type 2 diabetes. This combination therapy helps manage blood glucose levels. Diabetica Duo SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and treatment. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Inform your physician of any heart conditions before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring and blood tests (blood cell counts, liver function) may be recommended.

Uses of Glycofit-G1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glycofit-G1 Tablet SR:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycofit-G1 Extended-Release tablets should be administered with a meal.

Common Side effects of Glycofit-G1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glycofit-G1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycofit-G1 SR tablets should be administered with a meal.

How Glycofit-G1 Tablet SR works:

Glycofit-G1 SR tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Glycofit-G1 SR tablets is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glycofit-G1 SR tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Prolonged-release Glycofit-G1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glycofit-G1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Kidney function should be regularly monitored during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glycofit-G1 SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, Glycofit-G1 SR tablets are contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glycofit-G1 Tablet SR :

Should you forget a Glycofit-G1 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Glycofit-G1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Glycofit-G1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glycofit-G1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glycofit-G1 Tablet SR and seek immediate medical attention.
Glycofit-G1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 DM.
Glycofit-G1 SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glycofit-G1 Tablet SR's prolonged use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and balance problems (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glycofit-G1 Tablet SR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This is more likely if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medication is taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glycofit-G1 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glycofit-G1 Tablet SR
33
MRP 40
17% off